Should tenofovir ever be used in association with didanosine?

Should tenofovir ever be used in association with didanosine?

Bibliographic Details
Main Author:	Ricardo Sobhie Diaz
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702005000600001&lng=en&tlng=en

Similar Items

Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells
by: Saye H. Khoo, et al.
Published: (2011-06-01)

Risk Factors for CD4 Lymphopenia in Patients Treated With a Tenofovir/Didanosine High Dose-containing Highly Active Antiretroviral Therapy Regimen
by: Loungoussou Viviane
Published: (2005-12-01)

QT-prolonging drugs - should they ever be used?
by: A Okreglicki
Published: (2005-09-01)

A new model for the population pharmacokinetics of didanosine in healthy subjects
by: L.S. Velasque, et al.
Published: (2007-01-01)

Analysis of in vivo absorption of didanosine tablets in male adult dogs by HPLC
by: PatrÃcia Severino, et al.
Published: (2012-02-01)

Insulin resistance in people living with HIV is associated with exposure to thymidine analogues and/or didanosine and prior immunodeficiency
by: Julie Høgh, et al.
Published: (2022-05-01)

Should We Ever Pace for Carotid Sinus Syndrome?
by: Steve W. Parry
Published: (2020-04-01)

Efficacious Preclinical Repurposing of the Nucleoside Analogue Didanosine against COVID-19 Polymerase and Exonuclease
by: Amgad M. Rabie
Published: (2022-06-01)

Didanosine determination in diluted alkaline electrolyte by adsorptive stripping voltammetry at the mercury film electrode
by: Percio Augusto Mardini Farias, et al.
Published: (2012-08-01)

Preparation of gastro-resistant pellets containing chitosan microspheres for improvement of oral didanosine bioavailability
by: Patrícia Severino, et al.
Published: (2012-06-01)

Didanosine determination in diluted alkaline electrolyte by adsorptive stripping voltammetry at the mercury film electrode
by: PERCIO AUGUSTO MARDINI FARIAS, et al.
Published: (2012-08-01)

Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data
by: Fadhl M. Alakwaa
Published: (2020-04-01)

Why should we ever automate moral decision making?
by: Conitzer, V
Published: (2023)

Scoring methods for building genotypic scores: an application to didanosine resistance in a large derivation set.
by: Allal Houssaini, et al.
Published: (2013-01-01)

Solubility evaluation of didanosine: a comparison between the equilibrium method and intrinsic dissolution for biopharmaceutics classification purposes
by: André Bersani Dezani, et al.
Published: (2017-08-01)

“… there is no reason why it should ever stop”: Large-scale algorithmic composition
by: Nick Collins
Published: (2018-11-01)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
by: Andrea Ries Thurman, et al.
Published: (2019-01-01)

Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
by: Abrams, D, et al.
Published: (1999)

A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve people
by: Collier Ann C, et al.
Published: (2006-02-01)

A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide
by: Chanie Wassner PharmD, BCCCP, BCIDP, et al.
Published: (2020-04-01)

Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
by: Pobiner Bonnie F, et al.
Published: (2005-04-01)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
by: Aida N. Kawuma, et al.
Published: (2023-06-01)

Tenofovir-associated bone density loss
by: Iwen F Grigsby, et al.
Published: (2009-12-01)

A Rare Case of Didanosine-Induced Mid-Peripheral Chorioretinal Atrophy Identified Incidentally 11 Years after the Drug Cessation
by: Heba Joharjy, et al.
Published: (2022-05-01)

The tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the community.
Published: (2005-10-01)

The tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the community.
by: Arlene Chua, et al.
Published: (2005-10-01)

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
by: Darbyshire, J, et al.
Published: (2000)

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
by: Darbyshire, J, et al.
Published: (2000)

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
by: Darbyshire, J, et al.
Published: (2000)

Tenofovir-induced quadriparesis
by: Ashalatha Muppur, et al.
Published: (2020-01-01)

"As it ever was. As it ever was.": Between the Cyclical and the Apocalyptic in The Cabin in the Woods
by: Noah Simon Jampol
Published: (2020-06-01)

Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.
by: Shafer, R, et al.
Published: (1994)

Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy
by: Shafer, R, et al.
Published: (1995)

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
by: Sarah M Michienzi, et al.
Published: (2021-07-01)

Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide
by: Nicholas T. Funderburg, et al.
Published: (2016-11-01)

Bictegravir, Emtricitabine & Tenofovir Alafenamide-associated Acute Pancreatitis
by: Abdulmajeed Alharbi
Published: (2023-05-01)

As inconclusive as ever
by: Gardner, J
Published: (2019)

Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
by: Andrew Hill, et al.
Published: (2018-04-01)

Association of Tenofovir Use With Risk of Incident Heart Failure in HIV‐Infected Patients
by: Ruijun Chen, et al.
Published: (2017-04-01)

Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring
by: Andrea R. Thurman, et al.
Published: (2022-03-01)